{"name":"HBM BioVentures","permalink":"hbm-bioventures","crunchbase_url":"http://www.crunchbase.com/financial-organization/hbm-bioventures","homepage_url":"http://www.hbmbioventures.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"41-41-768-11-08","description":"","email_address":"","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":"","alias_list":"","created_at":"Sat Jan 24 04:49:05 UTC 2009","updated_at":"Wed Jun 24 11:13:25 UTC 2009","overview":"<p>As a venture capital company, HBM BioVentures is invested globally in some 40 mature emerging companies in the biotechnology/human medicine, diagnostics and medical technology sectors. The primary products of HBM BioVenturesâ€™ portfolio companies are either at an advanced stage of development or already available on the market. The company focuses on unquoted emerging companies, with two-thirds are invested in private companies that offer high value creation potential. This has enabled HBM BioVentures to carve out a unique and distinctive market position. HBM BioVentures has a broad shareholder base and is listed on the SIX Swiss Exchange (ticker: HBMN).</p>","image":{"available_sizes":[[[150,25],"assets/images/resized/0005/0482/50482v1-max-150x150.png"],[[156,27],"assets/images/resized/0005/0482/50482v1-max-250x250.png"],[[156,27],"assets/images/resized/0005/0482/50482v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"","address1":"Bundesplatz 1","address2":"CH-6300 Zug","zip_code":"","city":"","state_code":null,"country_code":"CHE","latitude":47.1706606,"longitude":8.5156577}],"relationships":[],"investments":[{"funding_round":{"round_code":"debt_round","source_url":"http://venturebeat.com/2008/06/24/broncus-technologies-lines-up-venture-debt-financing-for-emphysema-treatment/","source_description":"Broncus Technologies lines up venture debt financing for emphysema treatment","raised_amount":null,"raised_currency_code":"USD","funded_year":1000,"funded_month":1,"funded_day":1,"company":{"name":"Broncus Technologies, Inc. ","permalink":"broncus-technologies-inc","image":{"available_sizes":[[[150,29],"assets/images/resized/0003/4691/34691v1-max-150x150.png"],[[242,47],"assets/images/resized/0003/4691/34691v1-max-250x250.png"],[[242,47],"assets/images/resized/0003/4691/34691v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/story/esbatech-rounds-additional-22m-series-b/2008-08-07","source_description":"ESBATech rounds up $22M in second round","raised_amount":22000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":8,"funded_day":7,"company":{"name":"ESBATech","permalink":"esbatech","image":{"available_sizes":[[[150,54],"assets/images/resized/0005/0466/50466v1-max-150x150.png"],[[239,87],"assets/images/resized/0005/0466/50466v1-max-250x250.png"],[[239,87],"assets/images/resized/0005/0466/50466v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://zosanopharma.com/index.php?option=com_content&task=view&id=9&Itemid=93","source_description":"Zosano Pharma, Inc. Announces Funding Close Totaling $90 Million","raised_amount":90000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":11,"funded_day":15,"company":{"name":"Zosano Pharma","permalink":"zosano-pharma","image":{"available_sizes":[[[150,55],"assets/images/resized/0005/2868/52868v1-max-150x150.jpg"],[[250,92],"assets/images/resized/0005/2868/52868v1-max-250x250.jpg"],[[267,99],"assets/images/resized/0005/2868/52868v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.chemocentryx.com/news/2004/pr20040617.pdf","source_description":"ChemoCentryx Raises $33 Million in Private Financing","raised_amount":33000000,"raised_currency_code":"USD","funded_year":2004,"funded_month":6,"funded_day":17,"company":{"name":"ChemoCentryx","permalink":"chemocentryx","image":{"available_sizes":[[[127,77],"assets/images/resized/0005/4088/54088v1-max-150x150.jpg"],[[127,77],"assets/images/resized/0005/4088/54088v1-max-250x250.jpg"],[[127,77],"assets/images/resized/0005/4088/54088v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/zosano-pharma-inc-series-b-30m/","source_description":"Zosano Pharma, Inc.: Series B $30M","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":8,"funded_day":6,"company":{"name":"Zosano Pharma","permalink":"zosano-pharma","image":{"available_sizes":[[[150,55],"assets/images/resized/0005/2868/52868v1-max-150x150.jpg"],[[250,92],"assets/images/resized/0005/2868/52868v1-max-250x250.jpg"],[[267,99],"assets/images/resized/0005/2868/52868v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://deals.venturebeat.com/2007/03/22/chemocentryx-autoimmune-disease-drug-co-raises-2984m/","source_description":"ChemoCentryx, autoimmune disease drug co., raises $29.84M","raised_amount":29840000,"raised_currency_code":"USD","funded_year":2007,"funded_month":3,"funded_day":22,"company":{"name":"ChemoCentryx","permalink":"chemocentryx","image":{"available_sizes":[[[127,77],"assets/images/resized/0005/4088/54088v1-max-150x150.jpg"],[[127,77],"assets/images/resized/0005/4088/54088v1-max-250x250.jpg"],[[127,77],"assets/images/resized/0005/4088/54088v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"f","source_url":"http://venturebeat.com/2007/12/06/pelikan-tech-raises-69m-for-finger-friendly-diabetes-testing/","source_description":"Pelikan Tech to push â€œfinger friendlyâ€ diabetes testing","raised_amount":69000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":12,"funded_day":6,"company":{"name":"Pelikan Technologies","permalink":"pelikan-technologies","image":{"available_sizes":[[[150,55],"assets/images/resized/0004/1895/41895v1-max-150x150.png"],[[157,58],"assets/images/resized/0004/1895/41895v1-max-250x250.png"],[[157,58],"assets/images/resized/0004/1895/41895v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/kolltan-pharmaceuticals-inc-series-a-5m/","source_description":"Kolltan Pharmaceuticals, Inc.: Series A $5M","raised_amount":5000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":12,"company":{"name":"Kolltan Pharmaceuticals","permalink":"kolltan-pharmaceuticals","image":{"available_sizes":[[[150,44],"assets/images/resized/0006/2551/62551v1-max-150x150.jpg"],[[186,55],"assets/images/resized/0006/2551/62551v1-max-250x250.jpg"],[[186,55],"assets/images/resized/0006/2551/62551v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://venturebeat.com/2009/10/19/lux-biosciences-scores-50m-series-b-for-eye-cure/","source_description":"Lux Biosciences scores $50M Series B for eye cure","raised_amount":50000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":null,"company":{"name":"Lux Biosciences","permalink":"lux-biosciences","image":{"available_sizes":[[[123,82],"assets/images/resized/0006/3157/63157v1-max-150x150.jpg"],[[123,82],"assets/images/resized/0006/3157/63157v1-max-250x250.jpg"],[[123,82],"assets/images/resized/0006/3157/63157v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/nabriva-therapeutics-ag-series-b-22m/","source_description":"Nabriva Therapeutics, AG: Series B $22M","raised_amount":22000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":17,"company":{"name":"Nabriva Therapeutics","permalink":"nabriva-therapeutics","image":{"available_sizes":[[[150,92],"assets/images/resized/0006/4061/64061v1-max-150x150.jpg"],[[166,102],"assets/images/resized/0006/4061/64061v1-max-250x250.jpg"],[[166,102],"assets/images/resized/0006/4061/64061v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.probiodrug.de/index.php?id=28&tx_ttnews[tt_news]=53&cHash=39e2addbf8","source_description":"Probiodrug Closes Series B Financing Round exceeding EUR 36 Million (US$54 Million)","raised_amount":54000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":11,"funded_day":2,"company":{"name":"Probiodrug","permalink":"probiodrug","image":{"available_sizes":[[[150,34],"assets/images/resized/0006/4671/64671v1-max-150x150.jpg"],[[198,45],"assets/images/resized/0006/4671/64671v1-max-250x250.jpg"],[[198,45],"assets/images/resized/0006/4671/64671v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/story/ophthotech-nabs-30m-round-fund-amd-trial/2009-12-15?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FB0","source_description":"Ophthotech nabs $30M round to fund AMD trial","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":12,"funded_day":15,"company":{"name":"Ophthotech","permalink":"ophthotech","image":{"available_sizes":[[[150,25],"assets/images/resized/0006/9859/69859v1-max-150x150.jpg"],[[250,42],"assets/images/resized/0006/9859/69859v1-max-250x250.jpg"],[[368,62],"assets/images/resized/0006/9859/69859v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://www.finsmes.com/2009/12/ptc-therapeutics-raises-50m-in-equity.html","source_description":"PTC Therapeutics Raises 50M in Equity Financing","raised_amount":50000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":12,"funded_day":22,"company":{"name":"PTC Therapeutics","permalink":"ptc-therapeutics","image":{"available_sizes":[[[150,69],"assets/images/resized/0006/8365/68365v1-max-150x150.jpg"],[[208,97],"assets/images/resized/0006/8365/68365v1-max-250x250.jpg"],[[208,97],"assets/images/resized/0006/8365/68365v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.mtmlabs.com/us/index.php?option=com_content&view=article&id=109&Itemid=24","source_description":"mtm laboratories Extends Series C Financing Round by EUR 7 Million Bringing Total to EUR 39 Million (USD 57 Million) ","raised_amount":39000000,"raised_currency_code":"EUR","funded_year":2009,"funded_month":10,"funded_day":5,"company":{"name":"MTM Laboratories","permalink":"mtm-laboratories","image":{"available_sizes":[[[136,66],"assets/images/resized/0007/4521/74521v1-max-150x150.jpg"],[[136,66],"assets/images/resized/0007/4521/74521v1-max-250x250.jpg"],[[136,66],"assets/images/resized/0007/4521/74521v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.mtmlabs.com/us/index.php?option=com_content&view=article&id=5&Itemid=44","source_description":"History of mtm laboratories AG ","raised_amount":12000000,"raised_currency_code":"EUR","funded_year":2003,"funded_month":9,"funded_day":1,"company":{"name":"MTM Laboratories","permalink":"mtm-laboratories","image":{"available_sizes":[[[136,66],"assets/images/resized/0007/4521/74521v1-max-150x150.jpg"],[[136,66],"assets/images/resized/0007/4521/74521v1-max-250x250.jpg"],[[136,66],"assets/images/resized/0007/4521/74521v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.agensys.com/pressrelease_071207.html","source_description":"Agensys Raises $41 Million","raised_amount":41300000,"raised_currency_code":"USD","funded_year":2007,"funded_month":7,"funded_day":12,"company":{"name":"Agensys","permalink":"agensys","image":{"available_sizes":[[[149,65],"assets/images/resized/0007/9921/79921v1-max-150x150.jpg"],[[149,65],"assets/images/resized/0007/9921/79921v1-max-250x250.jpg"],[[149,65],"assets/images/resized/0007/9921/79921v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.adnexustx.com/pdf/news/20070809.pdf","source_description":"Adnexus Therapeutics Raises $15.5 Million in Series C Funding","raised_amount":15500000,"raised_currency_code":"USD","funded_year":2007,"funded_month":8,"funded_day":7,"company":{"name":"Adnexus","permalink":"adnexus","image":{"available_sizes":[[[150,61],"assets/images/resized/0008/0201/80201v1-max-150x150.jpg"],[[236,96],"assets/images/resized/0008/0201/80201v1-max-250x250.jpg"],[[236,96],"assets/images/resized/0008/0201/80201v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://venturebeat.com/2007/05/29/barofold-pulls-in-12m-for-protein-refolding-technology/","source_description":"BaroFold pulls in $12M for protein-refolding technology","raised_amount":12000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":5,"funded_day":29,"company":{"name":"BaroFold","permalink":"barofold","image":{"available_sizes":[[[150,37],"assets/images/resized/0008/0311/80311v1-max-150x150.jpg"],[[218,54],"assets/images/resized/0008/0311/80311v1-max-250x250.jpg"],[[218,54],"assets/images/resized/0008/0311/80311v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://www.sloning.com/index.php?option=com_content&task=view&id=21&Itemid=22","source_description":"Sloning BioTechnology GmbH Raised â‚¬ 4.7m in a First Closing of a Series E Equity Financing Round","raised_amount":4700000,"raised_currency_code":"EUR","funded_year":2007,"funded_month":11,"funded_day":null,"company":{"name":"Sloning BioTechnology","permalink":"sloning-biotechnology","image":{"available_sizes":[[[150,45],"assets/images/resized/0008/0493/80493v1-max-150x150.jpg"],[[250,76],"assets/images/resized/0008/0493/80493v1-max-250x250.jpg"],[[259,79],"assets/images/resized/0008/0493/80493v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://esbatech.com/pr/press_releases/esbatech_press_02082006.pdf","source_description":"ESBATech Closes USD 41M Series B Venture Financing","raised_amount":41000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":8,"funded_day":2,"company":{"name":"ESBATech","permalink":"esbatech","image":{"available_sizes":[[[150,54],"assets/images/resized/0005/0466/50466v1-max-150x150.png"],[[239,87],"assets/images/resized/0005/0466/50466v1-max-250x250.png"],[[239,87],"assets/images/resized/0005/0466/50466v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://chemocentryx.com/news/2006/pr20060824b.html","source_description":"ChemoCentryx Completes Series C Financing","raised_amount":17700000,"raised_currency_code":"USD","funded_year":2006,"funded_month":8,"funded_day":24,"company":{"name":"ChemoCentryx","permalink":"chemocentryx","image":{"available_sizes":[[[127,77],"assets/images/resized/0005/4088/54088v1-max-150x150.jpg"],[[127,77],"assets/images/resized/0005/4088/54088v1-max-250x250.jpg"],[[127,77],"assets/images/resized/0005/4088/54088v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://genizon.com/images/pdfs/press_releases_en/20060329_Genizon_Financing_PR_en.pdf","source_description":"GENIZON SECURES $12 MILLION IN SECURED CONVERTIBLE DEBENTURES","raised_amount":12000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":3,"funded_day":29,"company":{"name":"Genizon BioSciences","permalink":"genizon-biosciences","image":{"available_sizes":[[[110,132],"assets/images/resized/0004/9770/49770v1-max-150x150.png"],[[110,132],"assets/images/resized/0004/9770/49770v1-max-250x250.png"],[[110,132],"assets/images/resized/0004/9770/49770v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://onbiovc.com/nereus-pharmaceuticals-inc-series-e-20m/","source_description":"Nereus Pharmaceuticals, Inc.: Series E $20M","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":25,"company":{"name":"Nereus Pharmaceuticals","permalink":"nereus-pharmaceuticals","image":null}}},{"funding_round":{"round_code":"b","source_url":"http://www.mpexpharma.com/pr_20050809.html","source_description":"Mpex Pharmaceuticals Closes $32 Million Series B Financing","raised_amount":32000000,"raised_currency_code":"USD","funded_year":2005,"funded_month":8,"funded_day":9,"company":{"name":"Mpex Pharmaceuticals","permalink":"mpex-pharmaceuticals","image":{"available_sizes":[[[150,74],"assets/images/resized/0009/2230/92230v1-max-150x150.jpg"],[[185,92],"assets/images/resized/0009/2230/92230v1-max-250x250.jpg"],[[185,92],"assets/images/resized/0009/2230/92230v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://ptct.client.shareholder.com/releasedetail.cfm?ReleaseID=197021","source_description":"PTC THERAPEUTICS RAISES $26.6 MILLION IN PRIVATE PLACEMENT FINANCING","raised_amount":26600000,"raised_currency_code":"USD","funded_year":2005,"funded_month":11,"funded_day":10,"company":{"name":"PTC Therapeutics","permalink":"ptc-therapeutics","image":{"available_sizes":[[[150,69],"assets/images/resized/0006/8365/68365v1-max-150x150.jpg"],[[208,97],"assets/images/resized/0006/8365/68365v1-max-250x250.jpg"],[[208,97],"assets/images/resized/0006/8365/68365v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.sloning.com/index.php?option=com_content&task=view&id=30&Itemid=22","source_description":"Sloning BioTechnology closes new round of financing","raised_amount":3100000,"raised_currency_code":"EUR","funded_year":2005,"funded_month":5,"funded_day":18,"company":{"name":"Sloning BioTechnology","permalink":"sloning-biotechnology","image":{"available_sizes":[[[150,45],"assets/images/resized/0008/0493/80493v1-max-150x150.jpg"],[[250,76],"assets/images/resized/0008/0493/80493v1-max-250x250.jpg"],[[259,79],"assets/images/resized/0008/0493/80493v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.rctech.com/news/rct-news.php?articleID=120&articleYear=2007","source_description":"Cylene Pharmaceuticals Closes $44 Million Series C Financing","raised_amount":44000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":1,"funded_day":23,"company":{"name":"Cylene Pharmaceuticals","permalink":"cylene-pharmaceuticals","image":{"available_sizes":[[[150,54],"assets/images/resized/0010/3059/103059v1-max-150x150.png"],[[209,76],"assets/images/resized/0010/3059/103059v1-max-250x250.png"],[[209,76],"assets/images/resized/0010/3059/103059v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.socaltech.com/cylene_pharmaceuticals_gets___m/s-0031253.html","source_description":"Cylene Pharmaceuticals Gets $12M","raised_amount":12000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":24,"company":{"name":"Cylene Pharmaceuticals","permalink":"cylene-pharmaceuticals","image":{"available_sizes":[[[150,54],"assets/images/resized/0010/3059/103059v1-max-150x150.png"],[[209,76],"assets/images/resized/0010/3059/103059v1-max-250x250.png"],[[209,76],"assets/images/resized/0010/3059/103059v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2010/11/mtm-laboratories-raises-additional-7m.html","source_description":"mtm laboratories Raises Additional â‚¬7M in Series C Financing","raised_amount":7000000,"raised_currency_code":"EUR","funded_year":2010,"funded_month":11,"funded_day":8,"company":{"name":"MTM Laboratories","permalink":"mtm-laboratories","image":{"available_sizes":[[[136,66],"assets/images/resized/0007/4521/74521v1-max-150x150.jpg"],[[136,66],"assets/images/resized/0007/4521/74521v1-max-250x250.jpg"],[[136,66],"assets/images/resized/0007/4521/74521v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2010/11/vivacta-closes-4m-financing-round.html","source_description":"Vivacta Closes Â£4M Financing Round","raised_amount":4000000,"raised_currency_code":"GBP","funded_year":2010,"funded_month":11,"funded_day":18,"company":{"name":"Vivacta","permalink":"vivacta","image":{"available_sizes":[[[150,34],"assets/images/resized/0011/0823/110823v1-max-150x150.jpg"],[[250,57],"assets/images/resized/0011/0823/110823v1-max-250x250.jpg"],[[392,90],"assets/images/resized/0011/0823/110823v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2011/05/delenex-therapeutics-raises-19-3m.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Delenex Therapeutics Raises $19.3M","raised_amount":19300000,"raised_currency_code":"USD","funded_year":2011,"funded_month":5,"funded_day":3,"company":{"name":"Delenex Therapeutics","permalink":"delenex-therapeutics","image":{"available_sizes":[[[150,32],"assets/images/resized/0011/0186/110186v1-max-150x150.png"],[[250,54],"assets/images/resized/0011/0186/110186v1-max-250x250.png"],[[251,55],"assets/images/resized/0011/0186/110186v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2011/08/ellipse-technologies-closes-17-6m-series-private-equity-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Ellipse Technologies Closes $17.6M Series C Private Equity Financing","raised_amount":17600000,"raised_currency_code":"USD","funded_year":2011,"funded_month":8,"funded_day":2,"company":{"name":"Ellipse Technologies","permalink":"ellipse-technologies","image":{"available_sizes":[[[150,40],"assets/images/resized/0014/7529/147529v1-max-150x150.png"],[[250,68],"assets/images/resized/0014/7529/147529v1-max-250x250.png"],[[316,86],"assets/images/resized/0014/7529/147529v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2012/01/probiodrug-raises-e15m-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Probiodrug Raises €15M in Funding","raised_amount":15000000,"raised_currency_code":"EUR","funded_year":2012,"funded_month":1,"funded_day":4,"company":{"name":"Probiodrug","permalink":"probiodrug","image":{"available_sizes":[[[150,34],"assets/images/resized/0006/4671/64671v1-max-150x150.jpg"],[[198,45],"assets/images/resized/0006/4671/64671v1-max-250x250.jpg"],[[198,45],"assets/images/resized/0006/4671/64671v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2012/07/ptc-therapeutics-completes-30m-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"PTC Therapeutics Completes $30M Financing","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":7,"funded_day":23,"company":{"name":"PTC Therapeutics","permalink":"ptc-therapeutics","image":{"available_sizes":[[[150,69],"assets/images/resized/0006/8365/68365v1-max-150x150.jpg"],[[208,97],"assets/images/resized/0006/8365/68365v1-max-250x250.jpg"],[[208,97],"assets/images/resized/0006/8365/68365v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}